Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
47,000
Employees47,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
47,000
Employees47,000

LLY Key Statistics

Market cap
1.02T
Market cap1.02T
Price-Earnings ratio
53.78
Price-Earnings ratio53.78
Dividend yield
0.55%
Dividend yield0.55%
Average volume
2.89M
Average volume2.89M
High today
$1,091.00
High today$1,091.00
Low today
$1,063.02
Low today$1,063.02
Open price
$1,084.26
Open price$1,084.26
Volume
447.03K
Volume447.03K
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

As of today, Eli Lilly(LLY) shares are valued at $1,082.59. The company's market cap stands at 1.02T, with a P/E ratio of 53.78 and a dividend yield of 55.2%.

On 2026-01-23, Eli Lilly(LLY) stock moved within a range of $1,063.02 to $1,091.00. With shares now at $1,082.59, the stock is trading +1.8% above its intraday low and -0.8% below the session's peak.

Trading volume for Eli Lilly(LLY) stock has reached 447.03K, versus its average volume of 2.89M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.

LLY News

Investor's Business Daily 16m
Oral Wegovy Is Off To An Astronomical Launch. Will It Save Novo Nordisk Stock?

Why Eli Lilly Is The IBD Stock Of The Day — Again — As Its Novo Nordisk Rivalry Deepens 1/21/2026 Eli Lilly is Wednesday's IBD Stock Of The Day. Lilly shares a...

Oral Wegovy Is Off To An Astronomical Launch. Will It Save Novo Nordisk Stock?
TipRanks 25m
Bernstein Sees Eli Lilly Stock Hitting $1,300 Per Share

Wall Street brokerage Bernstein sees Eli Lilly’s (LLY) stock hitting $1,300 per share. Claim 50% Off TipRanks Premium Analysts at Bernstein have reiterated a...

Simply Wall St 2h
Eli Lilly’s Breakthrough Cancer Win And AI Push Shape Valuation Story

Eli Lilly (NYSE:LLY) received FDA Breakthrough Therapy designation for sofetabart mipitecan in platinum resistant ovarian cancer. The company also announced ne...

Eli Lilly’s Breakthrough Cancer Win And AI Push Shape Valuation Story

Analyst ratings

80%

of 30 ratings
Buy
80%
Hold
16.7%
Sell
3.3%

More LLY News

CNBC 3h
What obesity drugmakers see next in the market: More pills, easier access and drug combinations

Key Points Top executives from drugmakers big and small told CNBC that the next phase of the obesity drug market will be defined by a broader range of treatment...

What obesity drugmakers see next in the market: More pills, easier access and drug combinations
The Motley Fool 5h
Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026

This biotech has candidates in late-stage clinical development. Eli Lilly (LLY +0.82%) delivered a gain worthy of a technology growth stock last year. The phar...

Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026
TipRanks 6h
Eli Lilly, Novo Nordisk Set for Fierce Battle in India’s Obesity Drug Market as Sun Pharma Wins Wegovy Generic Nod

Pharma giants Eli Lilly (LLY) and Novo Nordisk (NVO) will face further competition in the crucial obesity drug market in India, as the country’s top drugmaker S...

24/7 Wall St. 21h
Broadcom and Eli Lilly Emerge as Market Leaders as Magnificent Seven Stocks Stall in 2026

Is the 2026 Market Rotation Already Underway? Here’s What Could Lead After the Magnificent 7 Quick Read Magnificent Seven stocks are in the red for 2026 as col...

The Motley Fool 22h
Eli Lilly Q2 2025 Earnings Call Transcript

Image source: The Motley Fool. Aug. 7, 2025 at 8:30 a.m. ET Call participants Chairman and Chief Executive Officer — David A. Ricks Chief Financial Officer — L...

Eli Lilly Q2 2025 Earnings Call Transcript
TipRanks 23h
Eli Lilly Expands Oncology Imaging Footprint With New Phase 1 PET Tracer Study

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Eli Lilly’s new Phase 1 imaging study, officia...

TipRanks 23h
Eli Lilly Advances Retatrutide With New Phase 3b Obesity Dosing Study

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerful invest...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.